Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Other financing activities (2019 - 2021)

Phio Pharmaceuticals' Other financing activities history spans 3 years, with the latest figure at $1000.0 for Q4 2021.

  • For Q4 2021, Other financing activities changed N/A year-over-year to $1000.0; the TTM value through Dec 2021 reached $1000.0, down 99.78%, while the annual FY2025 figure was $30000.0, 500.0% up from the prior year.
  • Other financing activities reached $1000.0 in Q4 2021 per PHIO's latest filing, down from $473000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $106.0 million in Q1 2019 to a low of -$15000.0 in Q1 2020.
  • Average Other financing activities over 3 years is $21.3 million, with a median of $52000.0 recorded in 2019.
  • The largest YoY upside for Other financing activities was 100.01% in 2020 against a maximum downside of 100.01% in 2020.
  • A 3-year view of Other financing activities shows it stood at $52000.0 in 2019, then surged by 809.62% to $473000.0 in 2020, then tumbled by 99.79% to $1000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Other financing activities are $1000.0 (Q4 2021), $473000.0 (Q2 2020), and -$15000.0 (Q1 2020).